Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 30+ AI models, with 0% extra fees
SOL ETF Continues to Attract Funds! Institutional Capital is Quietly Increasing Its Holdings in Solana
Latest data shows that Solana (SOL) spot ETF recorded a net inflow of $7.3314 million on the day, with institutional funds still steadily entering.
Looking at specific products:
Bitwise's BSOL had a single-day net inflow of $6.2012 million, becoming the main source of funds, with a total net inflow of $825 million historically.
VanEck's VSOL had a single-day net inflow of $1.1302 million.
As of now:
The total net asset value of SOL ETFs is approximately $874 million.
The ETF net asset ratio is about 1.77%.
The total net inflow historically has reached $1.02 billion.
From a fund structure perspective, SOL is gradually entering institutional portfolios. Although the scale is still in the early stages, continuous fund inflows are a more noteworthy signal.
In the market, what truly determines the trend is never short-term price fluctuations, but whether funds are willing to stay long-term.
When patient capital begins to deploy, the story is often just getting started.